Publication | Open Access
Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma
37
Citations
10
References
2020
Year
PRI-724(C-82) may be a novel drug for β-catenin-activated HCC therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1